公开(公告)号：US20130101616A1

公开(公告)日：2013-04-25

申请号：US13445812

申请日：2012-04-12

Applicant: James DAO ,  Tom C.S. DAO ,  David D. TONG ,  Leslie WILSON ,  Mary Ann JORDAN ,  William GERWICK

Inventor： James DAO ,  Tom C.S. DAO ,  David D. TONG ,  Leslie WILSON ,  Mary Ann JORDAN ,  William GERWICK

IPC: A61K36/539 ,  A61K36/537 ,  A61K31/704 ,  A61K31/519 ,  A61K31/337 ,  A61K31/437 ,  A61K36/074 ,  A61K31/7068

CPC classification number: A61K36/539 ,  A61K31/00 ,  A61K31/337 ,  A61K31/437 ,  A61K31/519 ,  A61K31/704 ,  A61K31/7068 ,  A61K36/074 ,  A61K36/185 ,  A61K36/537 ,  A61K36/82 ,  A61K41/00 ,  A61K45/06 ,  A61K2300/00

Abstract: Methods and compositions for prevention and therapy of cancer are provided. Compositions comprising therapeutically effective amounts of two or more of an extract of Ganoderma lucidum, an extract of Salvia miltiorrhiza and an extract of Scutellaria barbata and optionally a therapeutically effective amount of an extract of Hippophae rhamnoides are provided. Novel synergistic effects of the use of these compounds in combination therapy are disclosed. Embodiments further comprising therapeutically effective amounts of at least one chemotherapeutic agent are also provided.

Abstract translation: 提供了预防和治疗癌症的方法和组合物。 提供包含治疗有效量的灵芝提取物，丹参提取物和黄芩提取物和任选的治疗有效量的沙棘提取物的两种或更多种的组合物。 公开了在组合疗法中使用这些化合物的新的协同效应。 还提供还包含治疗有效量的至少一种化学治疗剂的实施方案。